Repligen | RGEN - 贸易债权人

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 6.32B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	贸易债权人	更改		日
Agilent	USD 602M		32M	2025-12
Align Technology	USD 123.72M		2.27M	2026-03
Bio Techne	USD 95.6M		3.97M	2026-03
BioMarin Pharmaceutical	USD 793.15M		34.12M	2026-03
Bristol-Myers Squibb	USD 4.23B		659M	2026-03
Bruker	USD 269.1M		53.2M	2026-03
Charles River Laboratories	USD 133.95M		14.85M	2026-03
Danaher	USD 1.79B		54M	2026-03
Dentsply International	USD 259M		41M	2026-03
General Electric Aerospace	USD 10.68B		605M	2026-03
Henry Schein	USD 1.04B		111M	2026-03
Illumina	USD 218M		22M	2026-03
IQVIA Holdings	USD 3.64B		112M	2026-03
Mettler Toledo International	USD 228.72M		37.91M	2026-03
Myriad Genetics	USD 32.6M		2.6M	2026-03
OraSure Technologies	USD 10.63M		4.11M	2026-03
Pacific Biosciences Of California	USD 13.61M		7.16M	2026-03
Pfizer	USD 4.51B		734M	2026-03
Repligen	USD 34.66M		4.65M	2026-03
Revvity	USD 169.68M		15.78M	2026-03
Standard Biotools	USD 8.01M		2.6M	2026-03
Thermo Fisher Scientific	USD 3.34B		278M	2026-03
Waters	USD 103.78M		11.95M	2025-12
West Pharmaceutical Services	USD 252.3M		1.4M	2026-03